Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS
NCT02912325
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT:
Daily administration: 2 tablets FaseMETS a day
Sponsor
MDM S.p.A.
Collaborators
[object Object]